Which class of drugs does Eslicarbazepine belong to and its role in the treatment of epilepsy?

Eslicarbazepine (Eslicarbazepine) is a new type of anti-epileptic drug (AED), which belongs to the class of sodium channel blockers. It is a structural derivative of carbamazepine (Carbamazepine) and oxcarbazepine (Oxcarbazepine). It stabilizes neuronal membrane potential by selectively inhibiting overactive sodium channels, thereby reducing the frequency and intensity of epileptic seizures. Eslicarbazepine has certain advantages over traditional sodium channel blockers in terms of tolerability and drug interactions.

Eslicarbazepine inhibits abnormal neuronal discharge and reduces neuronal excessive excitability by prolonging the inactivation state of sodium channels. This selective blocking of over-activated sodium channels allows it to have a good control effect on epileptic seizures while causing less interference with normal neural activity, thereby reducing side effects. Its active metabolite is mainly S-licarbazepine, which is the main anti-epileptic component of the drug.

In clinical practice, eslicarbazepine is mainly used as adjuvant or monotherapy for **focal onset seizures. In adults and children (depending on the approved age group), it significantly reduces the frequency of partial epilepsy seizures and improves patients' quality of life. Some studies have shown that eslicarbazepine is better tolerated and has a lower risk of dizziness, drowsiness, and hematologic side effects than carbamazepine.

Eslicarbazepine is convenient to take orally, and usually once a day can maintain stable blood concentration. Compared with other anti-epileptic drugs, it has fewer drug interactions, especially has little impact on CYP3A4 and liver enzyme induction drugs, making it suitable for patients who need to take combined drugs. During the medication period, blood routine, liver and kidney function still need to be monitored regularly, and the dose should be adjusted according to the patient's tolerance and clinical response to ensure efficacy and safety.

Reference materials:https://www.drugs.com/